What side effects are associated with this type of intervention?

The most common treatments for trigger finger, specifically the excision and incision of the A1 pulley, can have several side effects. These include pain, swelling, and stiffness at the surgical site. There is also a risk of infection, bleeding, and scarring. Some patients may experience nerve damage, which can lead to numbness or tingling in the affected finger. Additionally, there is a possibility of recurrence of trigger finger symptoms even after surgery. Overall, while these procedures are generally effective, they carry the typical risks associated with surgical interventions.

What prior FDA approvals exist?

The provided context does not mention specific FDA approvals or related drugs for the treatment of Trigger Finger, particularly those involving surgical procedures like excision or incision of the A1 pulley. Generally, Trigger Finger is commonly treated with non-surgical methods such as corticosteroid injections, which are FDA-approved for reducing inflammation and pain. When these methods fail, surgical options like the excision or incision of the A1 pulley are considered standard treatments to improve tendon gliding and reduce symptoms.

What other types of research exist?

Promising, novel alternatives to excision and incision of the A1 pulley for treating trigger finger include: 1) Sonographically guided percutaneous needle tenotomy, which uses ultrasound to guide a needle to release the tendon sheath, 2) Iontophoretic administration of dexamethasone sodium phosphate, a non-invasive method to deliver anti-inflammatory medication directly to the affected area, and 3) Platelet-rich plasma (PRP) injections, which use the patient's own blood components to promote healing and reduce inflammation.

← Back to Search

A1 Pulley Surgery Techniques for Trigger Finger

N/A

Recruiting

Led By Eric Wagner, MD, MS

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients undergoing surgery for trigger finger syndrome

Age 18 or older

Must not have

Individuals who are not yet adults (infants, children, teenagers)

Adults unable to consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial compares two surgical methods for treating trigger finger: removing or cutting a part of the tendon sheath. It focuses on patients who haven't improved with other treatments. The goal is to see which method better reduces pain and stiffness by helping the tendon move more freely.

Who is the study for?

This trial is for adults over 18 with trigger finger syndrome who are undergoing surgery and can give informed consent. It excludes those unable to consent, minors, pregnant women, and prisoners.

What is being tested?

The study compares two surgical treatments for trigger finger: excision (complete removal) versus incision (cutting) of the A1 pulley. The goal is to see which method offers better pain relief, less stiffness, and lower recurrence rates.

What are the potential side effects?

Potential side effects from both surgeries may include pain at the site of operation, swelling, infection risk, reduced mobility in the affected finger during recovery or scar tissue formation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am having surgery for trigger finger.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Select...

I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Change in patients' reported demand of daily activities

Change in patients' reported pain interference subjective score in social activities

Change in patients' reported pain interference subjective score in the day-to-day activities

+4 more

Other study objectives

Change in patients' reported Working status

Change in the pain score

Change in the range of motion (ROM)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: excision of the A1 pulleyExperimental Treatment1 Intervention

Group II: incision of the A1 pulley in the standard fashionActive Control1 Intervention

0 / 4Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

The most common treatments for Trigger Finger, particularly the surgical options of excision and incision of the A1 pulley, work by addressing the thickening of the A1 pulley or flexor tendon that impedes smooth tendon gliding. In excision, the A1 pulley is completely removed, which eliminates the constriction and allows the tendon to move freely within the sheath. In incision, the A1 pulley is cut to release the tension, similarly improving tendon movement. These procedures are crucial for patients as they directly target the mechanical obstruction causing pain, stiffness, and locking of the finger, thereby providing significant symptom relief and improving hand function.

Outcomes of repair of the lacerated A2 pulley with extensor retinaculum during primary flexor tendon repair.